Analysis

Wicked Will Boost Names. Just Not Elphaba or Glinda.

Jack Lin
Jack Lin· Founder & Editor-in-Chief
·7 min read
Naming Trend AnalysisSSA & Open Data

Wicked Part I opened on November 22, 2024, and is on track to be the highest-grossing first-month box office for any Broadway adaptation in history. Critics have been kind. Audiences have been kinder. The cultural moment is real. The naming question is whether any of this translates into a measurable bump for the names attached to the property — Elphaba, Glinda, Nessarose, Fiyero. The historical pattern, when looked at honestly, says no. The names that benefit from this kind of cultural moment are the actors' names, not the characters'. The data is clear. Broadway-derived character names underperform film-derived character names by roughly an order of magnitude.

The Frozen reference case

The cleanest comparison case is Frozen, the 2013 Disney animation. Anna and Elsa, the two lead characters' names, both received measurable bumps after the film's release. Anna had a small but real lift; Elsa, which had been steadily declining for decades, reversed and started climbing. The film moved both names. The mechanism was direct: parents heard the names many times in a film their children watched repeatedly, the names became familiar and warmly associated, and parents who would not have considered Elsa pre-2013 considered it post-2013.

This is what film-derived character naming bumps look like. Frozen also produced smaller halo effects on adjacent names — Olaf saw a tiny bump, Sven saw essentially none — but the dominant effect was on the lead character names. Frozen 2 in 2019 reinforced rather than replaced the original effect. The Frozen pattern is the well-documented benchmark for what mainstream animation can do for naming.

Broadway shows do not do this

Broadway shows, by contrast, almost never produce equivalent naming bumps. Hamilton was one of the most culturally dominant Broadway shows of the last fifty years. It produced no measurable bump for the names Alexander or Hamilton (both of which were already in the chart for other reasons). It produced no bump for Eliza, no bump for Angelica, no bump for Theodosia. The most cultural-impact-per-broadcast-minute Broadway show in modern history did essentially nothing to the SSA chart.

The reason is mechanical. Broadway shows reach much smaller audiences than mainstream films. Hamilton sold roughly 3 million tickets in its first three years. Frozen reached probably 100 million households in its first year. The exposure differential is two orders of magnitude. The naming-bump differential reflects the exposure differential. There is no way around this. A Broadway show cannot match a film's naming reach because it cannot match a film's audience reach.

The Wicked film, however, is a film

This is where Wicked is different from previous Broadway-derived projects. It is technically a film. The film will, when its full streaming run is added to its theatrical run, reach an audience approaching mainstream-animation scale. The names spoken in the film will be heard by tens of millions of people. The exposure differential that has historically suppressed Broadway-derived character naming will be substantially closed.

And yet the names that will benefit are still likely to be the actors' names rather than the characters' names. The reason this time is different from Frozen is the names themselves. Anna and Elsa were already-existing common names with broad cultural permission. Elphaba is not. Elphaba is a constructed name from L. Frank Baum's name (L-F-B becomes Elphaba) and reads to American ears as fundamentally synthetic. Glinda is closer to a real name but still reads as old-fashioned-novelty rather than usable. Fiyero reads as straightforwardly invented. Parents who would not have considered Elphaba pre-Wicked are not going to consider Elphaba post-Wicked, because the name still does not pass the basic test of sounding like a name a real human would carry.

The actor halo

What will get the bump is the actors' names. Cynthia Erivo, who plays Elphaba, has a name that is already in the SSA but climbing modestly. Cynthia, after Wicked Part I, will likely accelerate. Ariana Grande, who plays Glinda, has been in the public eye for a decade and has had her own existing naming influence — Ariana entered the chart around 2008 and has climbed steadily, with measurable acceleration after each major Grande career moment. Wicked will produce another acceleration. Even Gracie, the diminutive of Grace, may pick up a small bump because of Grande's frequent association with the name Gracie.

This is the actor-halo pattern. Films cast actors. Audiences register the actors more strongly than the characters in many cases, especially when the actors are already public figures with established cultural footprints. The character is, in effect, a temporary container for the actor's existing brand. The actor's name carries forward. The character's name stays in the film. This is a stable pattern in American naming bumps from films, and it holds even when the character names are perfectly normal English names that should, in theory, be easy to choose.

The Anna Frozen case revisited

Anna got a Frozen bump partly because Anna was already a viable name. Elsa got the Frozen bump partly because Elsa was a viable name in many European naming traditions and was just dormant in American usage. Both names had what we might call usability headroom — they could absorb a bump without requiring American parents to take a risk. Elphaba does not have usability headroom. The name is itself a risk regardless of its cultural support. Even with the Wicked film driving recognition, parents do not have a comfortable cultural template for Elphaba on a school registration form.

This is the diagnostic test for whether a film bump will translate. The character name has to already be culturally legible as a possible human name. If it is not, the film can drive recognition without driving adoption. The audience will recognize Elphaba in the abstract — they know the name, they know the green skin, they know the song — but they will not name children Elphaba in measurable numbers. The bump will land somewhere else.

The names that will probably bump

Beyond Cynthia and Ariana, the most likely beneficiaries of the Wicked release are the names that share phonetic or semantic territory with the project without being the actual character names. Glinda is unusable; Linda might see a tiny mid-century revival ride. Elphaba is unusable; Eloise might benefit from being adjacent to the green-witch-aesthetic moment. Greenleaf is not on most parents' lists; the broader green-coded naming territory might lift Greer, Olive, Sage, and Forest. The bump effects spread outward from the project rather than landing on the specific names.

Predicting the exact names that will benefit requires looking at the cultural moment more carefully than just the credits. Wicked has a specific aesthetic — emerald, witchy, theatrical, slightly campy, female-friendship-coded — and the names that will rise are the ones that share that aesthetic without being trapped by the property's specific naming choices. Watch for Eloise, Olive, Sage, and the Phoebe-adjacent group. Those are the candidates I would expect to ride the cultural moment without being burdened by the impossible character names.

The Phantom of the Opera comparison

Phantom of the Opera, which ran on Broadway for 35 years and produced a 2004 film adaptation, did almost nothing for naming. Christine, the lead character, was already a popular name before the show. The Phantom himself was nameless for most of the property and called Erik in the underlying novel. Erik did not bump. The 2004 film, despite being a major release, produced no measurable naming effect that the literature has been able to identify. This is the historical baseline for Broadway-to-film conversions. They mostly do nothing.

Wicked is the most likely Broadway-to-film conversion to break this pattern. The cultural moment is larger, the audience is larger, the marketing is heavier. But the names are the names, and the names are not built to absorb bumps. The film will probably produce some effect — non-zero, measurable in the data — but it will be smaller than the Frozen effect and smaller than the cultural moment would suggest. This is the gap between cultural visibility and naming traction. Wicked will be very visible. Its naming traction will be modest. The expensive lesson here is that not every cultural moment translates.

The May 2025 SSA release will tell us

The 2024 SSA cohort, released in May 2025, will not yet show much of the Wicked Part I effect — the film opened in late November and most 2024 babies were already named. The 2025 cohort, released in May 2026, will be the first proper test. Look at three lines: Elphaba (predicted to remain rare or absent), Glinda (predicted to remain rare or absent), and Cynthia (predicted to climb modestly with measurable acceleration in 2025). If those three predictions hold, the Broadway-vs-film pattern is confirmed for another major case.

The interesting outcome would be the opposite — Elphaba showing up in the chart as a real entry, Glinda accelerating from negligible into countable territory. That would suggest that something has changed about American naming permissiveness, that the constructed-name barrier has weakened, that parents are more willing to choose synthetic names than they were a decade ago. I do not think this will happen. The barrier is robust. But the test is worth running, and Wicked is the cleanest test case the data has had since Frozen. The answer arrives in eighteen months.

Data source: U.S. Social Security Administration. Analysis by NamesPop.

Found this helpful?

Share it with someone who’s picking a name.

More in Analysis

Popular Names

Keep Reading

Find the perfect name for your baby

Explore 100,000+ names with meanings, origins, and popularity trends.